LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 12 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 2. - Dataset (ID:20249)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | CGP60474 | 0.04 | uM | LJP5 | 72 | hr | 2543 | 5802 | 5752 | 1.0087 | 1.0148 |
MCF7 | NU7441 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6255 | 5905 | 1.0608 | 1.0573 |
MCF7 | PD173074 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6234 | 5445 | 1.1449 | 1.1423 |
MDA-MB-231 | Sirolimus | 0.04 | uM | LJP6 | 72 | hr | 1311 | 4261 | 4935 | 0.8639 | 0.8518 |
MCF7 | Seliciclib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5996 | 5905 | 1.0155 | 1.0149 |
MCF7 | QL-X-138 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3387 | 5445 | 0.6226 | 0.5715 |
SK-BR-3 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 2543 | 4361 | 5752 | 0.7581 | 0.5793 |
MCF7 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5485 | 5445 | 1.0072 | 1.0073 |
MCF7 | PF431396 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4828 | 5905 | 0.8175 | 0.8158 |
MCF7 | XMD11-50 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 4718 | 5445 | 0.8595 | 0.8378 |
MCF7 | Vemurafenib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5823 | 5905 | 0.9859 | 0.9864 |
MCF7 | WZ-4-145 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 3933 | 5445 | 0.7218 | 0.6937 |
MCF7 | TWS119 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6227 | 5905 | 1.0550 | 1.0522 |
MCF7 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 1958 | 5445 | 0.3614 | 0.1917 |
MCF7 | Crizotinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 4267 | 5905 | 0.7211 | 0.7069 |
MCF7 | PF477736 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 3686 | 5905 | 0.6243 | 0.5960 |
MCF7 | HG-6-64-01 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 6450 | 5445 | 1.1889 | 1.1853 |
MCF7 | Y39983 | 0.04 | uM | LJP6 | 72 | hr | 1389 | 5536 | 5445 | 1.0136 | 1.0098 |
SK-BR-3 | A443654 | 0.04 | uM | LJP6 | 72 | hr | 2543 | 1613 | 5418 | 0.2978 | -0.3416 |
MCF7 | Barasertib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 2234 | 5905 | 0.3783 | 0.2554 |
MCF7 | Pelitinib | 0.04 | uM | LJP5 | 72 | hr | 1389 | 5916 | 5905 | 1.0028 | 1.0029 |
MCF7 | AZD8330 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 2293 | 5905 | 0.3881 | 0.2706 |
MCF7 | LDN-193189 | 0.04 | uM | LJP5 | 72 | hr | 1389 | 6186 | 5905 | 1.0473 | 1.0446 |
MDA-MB-231 | WYE-125132 | 0.04 | uM | LJP6 | 72 | hr | 1311 | 3128 | 4935 | 0.6340 | 0.5758 |
MDA-MB-231 | OSI-027 | 0.04 | uM | LJP6 | 72 | hr | 1311 | 5123 | 4935 | 1.0380 | 1.0392 |